Two new TB vaccines show safety but limited protection
Two new vaccines to prevent tuberculosis (TB) are safe for use in adults and children, but they do…
New blood biomarker improves cancer risk detection in people with Lynch Syndrome
Researchers at The University of Texas MD Anderson Cancer Center have discovered a new blood-based biomarker that can…
Study reveals how inflammation disrupts lymph node structure in lymphoma
In aggressive lymphomas, inflammatory messengers reprogram the “conductors” of the immune system, causing lymph nodes structure to collapse.…
New nanoparticle therapy overcomes T cell exhaustion in solid tumors
Engineers at the University of Pennsylvania have developed a new type of lipid nanoparticle (LNP) that could one…
Math-based model helps optimize treatment for chronic eczema
Anyone with a chronic illness understands the struggle of living with a disease that is deeply unpredictable. Many…
Disrupting protein production in tumors triggers potent immune responses
A new study led by Pierre Close’s team (GIGA, Laboratory of Cancer Signaling, and WELRI Investigator) reveals how…
Protein partnership enhances innate immune sensing of viral RNA
Study reveals how two proteins cooperate in a key early step of antiviral detection, as reported by researchers…
Macrophage immune memory depends on lingering interferon gamma
Researchers from the University of California, Los Angeles, have discovered that immune cells known as macrophages remain poised…
Antibody feedback reshapes B cell selection during immune response
 A collaborative study published in Immunity from the Batista Lab and Liu Lab at the Ragon Institute, together…
MHC class II marks stronger immune response and longer survival in ovarian cancer
A new study sheds light on why some patients with the most aggressive form of ovarian cancer respond…
RNA micelles enable targeted chemotherapy without immune toxicity
A new study in mice hints at the potential to use tiny particles made with RNA molecules to…
Ride Cincinnati grant funds research on immune activating wafer for glioblastoma treatment
A multidisciplinary team of University of Cincinnati Cancer Center researchers has received a $40,000 Ride Cincinnati grant to…